Actively Recruiting

Age: 18Years +
All Genders
NCT05700175

Transcriptomic Study of Adult Population With Marfan Syndrome

Led by IRCCS Policlinico S. Donato · Updated on 2025-05-13

99

Participants Needed

1

Research Sites

212 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This project is designed to discover circulating biomarkers for aortic aneurysms in adults affected by Marfan Syndrome (MFS). The first aim is to identify circulating transcripts, protein-coding (mRNA) and not (ncRNAs), which show differential expression between three groups of adult patients affected by MFS, based on: presence or absence of thoracic aortic aneurysms (TAA) and indication of TAA-surgery. This obtained TAA\_MFS\_signature will then be correlated to fundamental biological parameters, like cytokines and chemokines relevant during inflammation and transcriptomic as well as epigenetics changes in aortic aneurysm tissue. Furthermore, the association of TAA\_MFS\_signature to genetic, clinical and instrumental parameters at present used for diagnosis and treatment, will be evaluated.

CONDITIONS

Official Title

Transcriptomic Study of Adult Population With Marfan Syndrome

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinically and genetically confirmed Marfan syndrome according to the revised Ghent criteria 2010
  • Signed informed consent
  • Patient receiving regular pharmacological prophylaxis or newly diagnosed
  • Patients without thoracic aortic aneurysms showing normal thoracic aortic diameters
  • Patients with stable thoracic aortic aneurysm dimensions over the 12 months before enrollment
  • Patients with indication for surgical correction due to uncontrolled aortic diameter increase, significant valve dysfunction, or familial dissection risk
Not Eligible

You will not qualify if you...

  • Patients with chronic or acute inflammatory conditions such as chronic liver disease
  • Patients with chronic renal insufficiency (creatinine > 1.5 mg/dl)
  • Patients with thyroid diseases
  • Pregnant patients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Irccs Policlinico San Donato

San Donato Milanese, Milan, Italy, 20097

Actively Recruiting

Loading map...

Research Team

F

Fabio Martelli, Dr

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here